PDMR/ PCA Dealings

RNS Number : 0981O

EKF Diagnostics Holdings PLC

05 October 2021

 

EKF Diagnostics Holdings plc
("EKF" or the "Company")

  PDMR/ PCA Dealings 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that the Board of EKF has been informed that on Friday 1 October, 2021, certain funds connected to Christopher Mills, Non-executive Chairman, sold a total of 1,275,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 84.0 pence per Ordinary Share.

Following this transaction, Christopher Mills' total direct and indirect interest in the Company is 130,875,000 Ordinary Shares, representing approximately 28.76% of the total voting rights over the Company's issued share capital.

The Notification of Dealing Form required in accordance with UK MAR is set out below and reflects the sale of 637,500 Ordinary Shares by each of the North Atlantic Smaller Companies Investment Trust plc ("NASCIT") and the Oryx International Growth Fund Limited ("Oryx"). 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Christopher Mills
2	Reason for the notification
a)	Position/status	Christopher Mills is Non-executive Chairman of the Company.  Mr. Mills is a partner and Chief Investment Officer of Harwood Capital LLP.  Harwood Capital LLP is Investment Manager to NASCIT. Mr Mills is also a director of Harwood Capital Management (Gibraltar) Limited, which is Investment Manager and Investment Adviser to Oryx.
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	EKF Diagnostics Holdings plc
b)	LEI	213800DXTF3EAUK1AR05
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of  £0.01 each
	Identification code	GB0031509804
b)	Nature of the transaction	Sale of shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£0.84	637,500
			£0.84	637,500
d)	Aggregated information
	- Aggregated volume	1,275,000
	- Price	£0.84
e)	Date of the transaction	1 October 2021
f)	Place of the transaction	London Stock Exchange

EKF Diagnostics Holdings plc		www.ekfdiagnostics.com
Christopher Mills, Non-executive Chairman		Tel: [phone]
Mike Salter, CEO
Richard Evans, FD & COO
Singer Capital Markets (Nominated Adviser & Joint Broker)			Tel: +44 ( 0)20 7496 3000
Aubrey Powell / George Tzimas / Tom Salvesen
Investec Bank plc (Joint Broker)		Tel: [phone]
Gary Clarence / Daniel Adams
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Lianne Cawthorne	Mob: [phone]

 

END

 

 

DSHUPGCCUUPGGWA